David Roman

“I wanted just to follow up on some of the commercial comments that were made earlier in the call.”

“I think you talked about visual visual visualizing excuse me other catheters on Aferra and how you were thinking about integration of some of the investments you're making on expanding the accessory business within CAS, as well as the potential to integrate some of the other established technologies onto Afera.”

“Maybe, Scott, I can come back to something you mentioned in your prepared remarks around 10% of the tax benefit being fully utilized by members. What are some of the actions that you can take to increase that utilization rate, and how do you think we would see that kind of flow through the performance of the business?”

“And maybe just a follow-up, as you think about appreciating your comments on the macro environment and some of the political and other uncertainty that have faced pharma companies, but coming out of Q1, most companies were raising their revenue outlets for the year.”

“Maybe we could just dive into the results here for Q1 in a little bit more detail.”